Serum Phosphorus Concentrations in the Third National Health and Nutrition Examination Survey (NHANES III)

American Journal of Kidney Diseases

Volumn 53, Issue 3, 2009, Pages 399-407

  de Boer, Ian H ^a   Rue, Tessa C ^b   Kestenbaum, Bryan ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

cardiovascular; kidney; nutritional; Phosphorus

Indexed keywords

PHOSPHORUS;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONCENTRATION (PARAMETERS); CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIETARY INTAKE; ETHNICITY; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; HEALTH SURVEY; HISPANIC; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MALE; NUTRITIONAL ASSESSMENT; PHOSPHATE BLOOD LEVEL; SCORING SYSTEM;

ADULT; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHORUS; PHOSPHORUS, DIETARY; RISK FACTORS;

EID: 60149109219     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.07.036     Document Type: Article

References (36)

1. Block G.A., Hulbert-Shearon T.E., Levin N.W., and Port F.K. Association of serum phosphorus and calcium x phosphorus product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 31 (1998) 607-617
2. Stevens L.A., Djurdjev O., Cardew S., Cameron E.C., and Levin A. Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: Evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol 15 (2004) 770-779
3. Young E.W., Albert J.M., Satayathum S., et al. Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int 67 (2005) 1179-1187
4. Giachelli C.M. Vascular calcification: In vitro evidence for the role of inorganic phosphorus. J Am Soc Nephrol 14 suppl 4 (2003) S300-S304
5. Jono S., McKee M.D., Murry C.E., et al. phosphorus regulation of vascular smooth muscle cell calcification. Circ Res 87 (2000) E10-E17
6. Dhingra R., Sullivan L.M., Fox C.S., et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167 (2007) 879-885
7. Kestenbaum B., Sampson J.N., Rudser K.D., et al. Serum phosphorus levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16 (2005) 520-528
8. Tonelli M., Sacks F., Pfeffer M., Gao Z., and Curhan G. Relation between serum phosphorus level and cardiovascular event rate in people with coronary disease. Circulation 112 (2005) 2627-2633
9. Gutierrez O., Isakova T., Rhee E., et al. Fibroblast growth factor-23 mitigates hyperphosphorusmia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16 (2005) 2205-2215
10. Hruska K., and Slatopolsky E. Disorders of Phosphorus, calcium, and magnesium metabolism. In: Schrier R., and Gottschalk C. (Eds). Diseases of the Kidney vol 3 (1996), Little, Brown, London, UK 2477-2526
11. Menon V., Greene T., Pereira A.A., et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. Am J Kidney Dis 46 (2005) 455-463
12. National Center for Health Statistics. Plan and operations of the Third National Health and Nutrition Examination Survey 1988-1994. National Center for Health Statistics. Vital Health Stat 1 32 (1994)
13. Hu F.B., Rimm E., Smith-Warner S.A., et al. Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr 69 (1999) 243-249
14. Karvetti R.L., and Knuts L.R. Validity of the 24-hour dietary recall. J Am Diet Assoc 85 (1985) 1437-1442
15. Gunter E., Lewis B., and Koncikowski S. Laboratory methods used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 (CD-ROM) (1996), Centers for Disease Control and Prevention, Hyattsville, MD
16. Genuth S., Alberti K.G., Bennett P., et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
17. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
18. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
19. Coresh J., Astor B.C., McQuillan G., et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 39 (2002) 920-929
20. Levey A.S., Greene T., Kusek J.W., and Beck G.J. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11 (2000) 0828A (abstr)
21. Mattix H.J., Hsu C.Y., Shaykevich S., and Curhan G. Use of the albumin/creatinine ratio to detect microalbuminuria: Implications of sex and race. J Am Soc Nephrol 13 (2002) 1034-1039
22. Boukhris R., and Becker K.L. Calcification of the aorta and osteoporosis. A roentgenographic study. JAMA 219 (1972) 1307-1311
23. Kates D.M., Sherrard D.J., and Andress D.L. Evidence that serum phosphorus is independently associated with serum PTH in patients with chronic renal failure. Am J Kidney Dis 30 (1997) 809-813
24. Isakova T., Gutierrez O., Shah A., et al. Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J Am Soc Nephrol 19 (2008) 615-623
25. Mataix J., Aranda P., Lopez-Jurado M., Sanchez C., Planells E., and Llopis J. Factors influencing the intake and plasma levels of calcium, phosphorus and magnesium in southern Spain. Eur J Nutr 45 (2006) 349-354
26. Kestenbaum B. phosphorus metabolism in the setting of chronic kidney disease: Significance and recommendations for treatment. Semin Dial 20 (2007) 286-294
27. Kaplan R.A., Haussler M.R., Deftos L.J., Bone H., and Pak C.Y. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 59 (1977) 756-760
28. Murer H., Hernando N., Forster I., and Biber J. Proximal tubular phosphorus reabsorption: Molecular mechanisms. Physiol Rev 80 (2000) 1373-1409
29. Biber J., Forgo J., and Murer H. Modulation of Na+-Pi cotransport in opossum kidney cells by extracellular phosphorus. Am J Physiol 255 (1988) C155-C161
30. Bowe A.E., Finnegan R., Jan de Beur S.M., et al. FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. Biochem Biophys Res Commun 284 (2001) 977-981
31. Kempson S.A., Lotscher M., Kaissling B., Biber J., Murer H., and Levi M. Parathyroid hormone action on phosphate transporter mRNA and protein in rat renal proximal tubules. Am J Physiol 268 (1995) F784-F791
32. Yoshida T., Yoshida N., Monkawa T., Hayashi M., and Saruta T. Dietary phosphorus deprivation induces 25-hydroxyvitamin D(3) 1alpha-hydroxylase gene expression. Endocrinology 142 (2001) 1720-1726
33. Hedback G., and Oden A. Increased risk of death from primary hyperparathyroidism-An update. Eur J Clin Invest 28 (1998) 271-276
34. Wang T.J., Pencina M.J., Booth S.L., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 117 (2008) 503-511
35. Watson K. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96 (1997) 1755-1760
36. Portale A.A., Halloran B.P., and Morris Jr. R.C. Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D. J Clin Invest 80 (1987) 1147-1154